INSIGHTS ON CLINICAL TRIAL DESIGN
-
FDA Guidance On Payment And Reimbursement To Research Subjects
Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.
-
Stop Guessing On Trial Feasibility: Simulating Patient Recruitment With AI
Simulate enrollment, endpoints, and criteria with integrated data and synthetic populations to test protocol feasibility early — refining design and reducing recruitment and regulatory risks.
-
The Benefit Of Applying Corporate Meetings Management Best Practices
Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.
-
Smarter, More Accurate Patient Matching Enhances Trial Efficiency
Even when patient recruitment criteria grows complex, this direct-to-data approach can pinpoint precise patients needed and provide an alert to your team when they are found.
-
Supporting Participants Through National Travel Disruptions12/10/2025
A sudden travel shutdown threatened a critical clinical visit. Rapid rescheduling, coordinated logistics, and clear communication ensured engagement and the ability to continue without interruption.
-
When Your Protocol Includes Ocular Endpoints4/6/2026
Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
-
Solutions To The Challenges Of Oncology Trials5/6/2025
This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
-
Leading With Purpose: Meg Hooton's Global Journey in Biotech1/14/2026
Biotech leadership requires vision, adaptability, and purpose. Aligning values with strategy and fostering collaboration empowers teams and drives innovation in a rapidly evolving industry.
-
Applying AI to Study Simulation: From Design to Analysis5/12/2026
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.